| Application no. and date | 03743368.7 (espacenet) (Federated) (European Patent Register), 20030303 | | Patent/reg. no. and date | DK/EP 1485094, 20120704 | | Publication date | 20041215 | | Priority no. and date | DE 10209985, 20020307, DE 10245624, 20020930 | | EP pub. no. and date |
EP 1485094 20041215 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Straße 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 156865 | | Inventor | HAUEL, Norbert, Marderweg 12
88433 Schemmerhofen, DE,
BRAUNS, Ulrich, Alleenstrasse 54
88400 Biberach, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 9/16 (2006.01) , A61K 9/50 (2006.01) , A61P 7/02 (2006.01) | | Title | DOSERINGSFORM TIL ORAL INDGIVELSE AF 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO]-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO]-PROPIONSYRE-ETHYLESTER ELLER DETS SALTE | | Int. application no. | EP2003002141 | | Int. publication no. | WO2003074056 | | Related patent (certificate) | CA 2012 00054 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
